1. Home
  2. CRVS vs RFI Comparison

CRVS vs RFI Comparison

Compare CRVS & RFI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CRVS
  • RFI
  • Stock Information
  • Founded
  • CRVS 2014
  • RFI 1992
  • Country
  • CRVS United States
  • RFI United States
  • Employees
  • CRVS N/A
  • RFI N/A
  • Industry
  • CRVS Biotechnology: Pharmaceutical Preparations
  • RFI Investment Managers
  • Sector
  • CRVS Health Care
  • RFI Finance
  • Exchange
  • CRVS Nasdaq
  • RFI Nasdaq
  • Market Cap
  • CRVS 305.4M
  • RFI 323.2M
  • IPO Year
  • CRVS 2016
  • RFI N/A
  • Fundamental
  • Price
  • CRVS $5.75
  • RFI $12.10
  • Analyst Decision
  • CRVS Strong Buy
  • RFI
  • Analyst Count
  • CRVS 4
  • RFI 0
  • Target Price
  • CRVS $15.00
  • RFI N/A
  • AVG Volume (30 Days)
  • CRVS 518.7K
  • RFI 69.8K
  • Earning Date
  • CRVS 08-07-2025
  • RFI 01-01-0001
  • Dividend Yield
  • CRVS N/A
  • RFI 8.25%
  • EPS Growth
  • CRVS N/A
  • RFI N/A
  • EPS
  • CRVS N/A
  • RFI N/A
  • Revenue
  • CRVS N/A
  • RFI N/A
  • Revenue This Year
  • CRVS N/A
  • RFI N/A
  • Revenue Next Year
  • CRVS N/A
  • RFI N/A
  • P/E Ratio
  • CRVS N/A
  • RFI N/A
  • Revenue Growth
  • CRVS N/A
  • RFI N/A
  • 52 Week Low
  • CRVS $2.54
  • RFI $9.62
  • 52 Week High
  • CRVS $10.00
  • RFI $12.52
  • Technical
  • Relative Strength Index (RSI)
  • CRVS 65.10
  • RFI 52.30
  • Support Level
  • CRVS $5.28
  • RFI $11.89
  • Resistance Level
  • CRVS $5.64
  • RFI $12.07
  • Average True Range (ATR)
  • CRVS 0.30
  • RFI 0.09
  • MACD
  • CRVS 0.03
  • RFI 0.01
  • Stochastic Oscillator
  • CRVS 77.70
  • RFI 60.71

About CRVS Corvus Pharmaceuticals Inc.

Corvus Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing product candidates that precisely target proteins that are critical to immune cell maturation and function. Its product candidate, soquelitinib, is designed to bind specifically to a protein, interleukin 2 inducible T cell kinase (ITK), involved in T cell activation, T cell receptor signaling and T cell differentiation and function. The other products include Ciforadenant (CPI-444) and Mupadolimab (CPI-006).

About RFI Cohen & Steers Total Return Realty Fund Inc.

Cohen & Steers Total Return Realty Fund Inc is a diversified, closed-end management investment company. Its investment objective is to achieve a high total return through investment in real estate securities. The Fund invests majority of its total assets in the equity securities of real estate companies under normal circumstances, which includes common shares, REITs, rights or warrants, convertible securities, and preferred shares.

Share on Social Networks: